Inmune Bio, Inc. — Director's Dealing 2020

Jan 30, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Inmune Bio, Inc. (INMB)
CIK: 0001711754
Period of Report: 2020-01-27

Reporting Person: Powers Linda F (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-01-27	Common Stock	S	220000	$4.60	Disposed	210000	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	700000	Indirect

Footnotes

F1: Shares held in name of Toucan Capital. Ms. Powers has voting and dispositive power over these shares.